← Leaderboards
Lisa A Carey
Univ Of North Carolina Chapel Hill
$11,034,788
Attributed
$13,523,111
Total exposure
17
Grants
13
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.1M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$22,788,811 · 18
By mechanism
P50$10,665,289 · 5
UG1$3,467,209 · 1
R01$3,398,108 · 1
U10$2,766,626 · 1
P30$1,266,920 · 4
U01$639,882 · 1
Top collaborators
- Matthew I Milowsky7 shared
- Charles M Perou6 shared
- Henry Shelton Earp2 shared
- Elizabeth C Dees1 shared
- Ellen L Jones1 shared
- Linda Van Le1 shared
Most similar at Univ Of North Carolina Chapel Hill
Same institution · by research overlap
- Philip Alan May$37,075,560
- Harsha Thirumurthy$12,190,121
- Katherine A. Hoadley$3,478,334
- Stephanie Christine Zerwas$715,474
- Shelton Earp$2,825,805
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchFundingClinical TrialsProgramsTranslational ResearchFacultyLeadershipMalignant Breast NeoplasmDesignWomanGenomicsGrantNorth CarolinaResearch PersonnelBasic ScienceMalignant NeoplasmsCancer CenterDisciplinePublishingSuccessBreastInvestmentsAnticancer ResearchAward
Grant awards (72)
SPORE in Breast Cancer$2,348,589
P50 · FY2025 · CA
Elucidating the molecular mechanisms of metastasis organ tropism$639,882
U01 · FY2025 · CA
Optimizing prognostic and predictive algorithms using residual disease (RD) genomic biomarkers in HER2+ and TNBC$596,748
R01 · FY2025 · CA · contact PI
UNC Lead Academic Participating Site$454,679
UG1 · FY2025 · CA · contact PI
Career Enhancement Program$76,135
P50 · FY2025 · CA · contact PI
SPORE in Breast Cancer$2,268,690
P50 · FY2024 · CA
UNC Lead Academic Participating Site$454,681
UG1 · FY2024 · CA · contact PI
Career Enhancement Program$74,640
P50 · FY2024 · CA · contact PI
Breast Cancer Research Program$42,152
P30 · FY2024 · CA · contact PI
Optimizing HER2-targeting using RNA- and DNA-based predictive algorithms$545,651
R01 · FY2023 · CA · contact PI
UNC Lead Academic Participating Site$504,995
UG1 · FY2023 · CA · contact PI
Breast Cancer Research Program$46,834
P30 · FY2023 · CA · contact PI
SPORE in Breast Cancer$2,324,485
P50 · FY2022 · CA
UNC Lead Academic Participating Site$504,963
UG1 · FY2022 · CA · contact PI
Optimizing HER2-targeting using RNA- and DNA-based predictive algorithms$485,168
R01 · FY2022 · CA · contact PI
Career Enhancement Program$81,026
P50 · FY2022 · CA · contact PI
Breast Cancer Research Program$46,834
P30 · FY2022 · CA · contact PI
SPORE in Breast Cancer$2,323,936
P50 · FY2021 · CA
Optimizing HER2-targeting using RNA- and DNA-based predictive algorithms$542,931
R01 · FY2021 · CA · contact PI
UNC Lead Academic Participating Site$537,489
UG1 · FY2021 · CA · contact PI
Career Enhancement Program$81,007
P50 · FY2021 · CA · contact PI
Breast Cancer Research Program$46,834
P30 · FY2021 · CA · contact PI
Optimizing HER2-targeting using RNA- and DNA-based predictive algorithms$616,954
R01 · FY2020 · CA · contact PI
UNC Lead Academic Participating Site$505,201
UG1 · FY2020 · CA · contact PI
Career Enhancement Program$79,948
P50 · FY2020 · CA · contact PI
Breast Cancer Research Program (Program 7)$39,437
P30 · FY2020 · CA · contact PI
Optimizing HER2-targeting using RNA- and DNA-based predictive algorithms$610,656
R01 · FY2019 · CA · contact PI
UNC Lead Academic Participating Site$505,201
UG1 · FY2019 · CA · contact PI
Career Enhancement Program$258,168
P50 · FY2019 · CA · contact PI
Breast Cancer Research Program (Program 7)$38,225
P30 · FY2019 · CA · contact PI
NCTN Lead Academic Participating Sites Application$623,046
U10 · FY2018 · CA · contact PI
Career Enhancement Program$87,144
P50 · FY2018 · CA · contact PI
Breast Cancer Research Program (Program 7)$39,435
P30 · FY2018 · CA · contact PI
Breast Cancer Research Program (Program 7)$2,968
P30 · FY2018 · CA · contact PI
Breast Cancer Research Program (Program 7)$2,101
P30 · FY2018 · CA · contact PI
Breast Cancer Research Program (Program 7)$1,366
P30 · FY2018 · CA · contact PI
NCTN Lead Academic Participating Sites Application$454,315
U10 · FY2017 · CA · contact PI
Breast Cancer Research Program (Program 7)$38,686
P30 · FY2017 · CA · contact PI
NCTN Lead Academic Participating Sites Application$474,318
U10 · FY2016 · CA · contact PI
Breast Cancer Research Program (Program 7)$38,921
P30 · FY2016 · CA · contact PI
NCTN Lead Academic Participating Sites Application$591,897
U10 · FY2015 · CA · contact PI
Breast Cancer Research$173,211
P30 · FY2015 · CA · contact PI
NCTN Lead Academic Participating Sites Application$623,050
U10 · FY2014 · CA · contact PI
Breast Cancer Research$163,380
P30 · FY2014 · CA · contact PI
Breast Cancer Research$169,861
P30 · FY2013 · CA · contact PI
Academic Training in Oncology at the University of North Carolina at Chapel Hill$255,067
T32 · FY2012 · CA · contact PI
Breast Cancer Research$186,853
P30 · FY2012 · CA · contact PI
Academic Training in Oncology at the University of North Carolina at Chapel Hill$70,772
T32 · FY2012 · CA · contact PI
Breast Cancer Research$2,552
P30 · FY2012 · CA · contact PI
Academic Training in Oncology at the University of North Carolina at Chapel Hill$220,020
T32 · FY2011 · CA · contact PI
Breast Cancer Research$187,270
P30 · FY2011 · CA · contact PI
Developmental Research Program$141,030
P50 · FY2010 · CA · contact PI
Developmental Research Program$141,210
P50 · FY2009 · CA · contact PI
Developmental Research Program$141,368
P50 · FY2008 · CA · contact PI
Developmental Research Program$137,983
P50 · FY2007 · CA · contact PI
LCCC 0403: PHASE II CETUXIMAB ALONE AND IN COMBINATION WITH CARBOPLATIN$750
M01 · FY2007 · RR · contact PI
Developmental Research Program$99,930
P50 · FY2006 · CA · contact PI
LCCC 9818: STAGE IIB, STAGE IIIA/B STAGE IV BREAST CANCER$1,239
M01 · FY2006 · RR · contact PI
LCCC 9818: STAGE IIB, STAGE IIIA/B STAGE IV BREAST CANCER$21,363
M01 · FY2005 · RR
LCCC 9818: Stage IIB, Stage IIIA/B Stage IV Breast Cancer$15,566
M01 · FY2004 · RR
CORRELATION OF MARKER WITH RESPONSE TO CHEMOTHERAPY$0
P50 · FY2002 · CA
CORRELATION OF MARKER WITH RESPONSE TO CHEMOTHERAPY$0
P50 · FY2001 · CA
DOXORUBICIN &CYCLOPHOSPHAMIDE &PACLITAXEL W/ HERCEPTIN$0
M01 · FY2000 · RR
TAMOXIFEN &RALOXIFENE FOR PREVENTTION OF BREAST CANCER$0
M01 · FY2000 · RR
TAMOXIFEN &RALOXIFENE FOR PREVENTTION OF BREAST CANCER$0
M01 · FY2000 · RR
TAMOXIFEN &RALOXIFENE FOR PREVENTTION OF BREAST CANCER$0
M01 · FY2000 · RR
MOLECULAR MARKERS W/ RESPONSE TO CHEMOTHERAPY IN BREAST CA$0
M01 · FY2000 · RR
MOLECULAR MARKERS W/ RESPONSE TO CHEMOTHERAPY IN BREAST CA$0
M01 · FY2000 · RR
MOLECULAR MARKERS W/ RESPONSE TO CHEMOTHERAPY IN BREAST CA$0
M01 · FY2000 · RR
MOLECULAR MARKERS W/ RESPONSE TO CHEMOTHERAPY IN BREAST CA$0
M01 · FY2000 · RR
DOXORUBICIN &CYCLOPHOSPHAMIDE &PACLITAXEL W/ HERCEPTIN$0
M01 · FY2000 · RR
DOXORUBICIN &CYCLOPHOSPHAMIDE &PACLITAXEL W/ HERCEPTIN$0
M01 · FY2000 · RR